Bemarituzumab Biosimilar (FGFR2 / CD332 Reference Antibody)
Bemarituzumab is a first-in-class, humanized IgG1 monoclonal antibody against FGFR2b (a FGF receptor) . Bemarituzumab blocks fibroblast growth factors from binding and activating FGFR2b. Bemarituzumab has the potential for cancer research.
Product Specifications
Target
Bemarituzumab Biosimilar (Anti-FGFR2 / CD332 Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation; Cell Biology
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx449778-01 10x 96 Tests
Induced Myeloid Leukemia Cell Differentiation Protein (MCL1) Antibody (ATTO488)
Sign In for Pricing
View Details abx449778-02 5x 96 Tests
Induced Myeloid Leukemia Cell Differentiation Protein (MCL1) Antibody (ATTO488)
Sign In for Pricing
View Details abx449778-03 100 µg
Induced Myeloid Leukemia Cell Differentiation Protein (MCL1) Antibody (ATTO488)
Sign In for Pricing
View Details abx449778-04 96 Tests
Induced Myeloid Leukemia Cell Differentiation Protein (MCL1) Antibody (ATTO488)
Sign In for Pricing
View Details 
